About Astraazin Pharmaceuticals
Astraazin Pharmaceuticals is a company. The company has 30 employees as of March 29, 2024. Astraazin Pharmaceuticals offers products and services including Alexit-M and Hempack.
- Employees 30 as on 29 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Astraazin Pharmaceuticals Pvt. Ltd
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$438.5 K (USD)-17.19as on Mar 31, 2021
-
Net Profit
$3.53 K (USD)84.36as on Mar 31, 2021
-
EBITDA
$5.03 K (USD)70.37as on Mar 31, 2021
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
30
as on Mar 29, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Astraazin Pharmaceuticals
Astraazin Pharmaceuticals offers a comprehensive portfolio of products and services, including Alexit-M and Hempack.
A pharmaceutical product is manufactured for health-related applications.
Another pharmaceutical product is developed for specific medicinal uses.
Funding Insights of Astraazin Pharmaceuticals
Detailed funding history for Astraazin Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Astraazin Pharmaceuticals
Investment portfolio details for Astraazin Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Astraazin Pharmaceuticals
Detailed financials for Astraazin Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Astraazin Pharmaceuticals Comparisons
Peer comparison for Astraazin Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Astraazin Pharmaceuticals
Detailed competitors of Astraazin Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Astraazin Pharmaceuticals
Complete news archive for Astraazin Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Astraazin Pharmaceuticals
As of Mar 29, 2024, the latest employee count at Astraazin Pharmaceuticals is 30.
Annual revenue of Astraazin Pharmaceuticals is $438.5K as on Mar 31, 2021.
Astraazin Pharmaceuticals was established in 2000 with core values such as integrity and excellence, starting from a small capital and a team of 10 employees. It has grown into a fast-expanding company offering a wide range of medicinal products globally, focusing on affordability and quality through contract manufacturing and research services. Operations are managed from locations in India, emphasizing innovation in fixed-dose combinations and accessibility of medicines, while contributing to societal and environmental concerns.
Astraazin Pharmaceuticals offers Alexit-M and Hempack.